StockWatch
·
Pharmaceuticals
Rights Issue27 May 2026, 09:31 pm

Natural Capsules' Material Subsidiary Approves Rights Issue of ₹1.11 Cr

AI Summary

Natural Capsules Ltd's material subsidiary, Natural Biogenex Private Limited, approved a rights issue of 11,11,200 equity shares at ₹10 each, aggregating to ₹1,11,12,000 in its board meeting held on May 27, 2026. The rights issue is for cash at par.

Key Highlights

  • Natural Biogenex approves rights issue of 11,11,200 equity shares.
  • The rights issue is priced at ₹10 per share.
  • The total value of the rights issue is ₹1,11,12,000.
  • The decision was made at the board meeting on May 27, 2026.